Chanda Sanjay - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 15, 2024, Chanda Sanjay's relationship to AN2 Therapeutics, Inc. (ANTX) is Officer (Chief Development Officer), and currently has 28,235 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Chanda Sanjay - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 16, 2024 | Acquisition -- (Common Stock) | 27500 | 0 | 28235 |